🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Prostate › Maryland

Qorannoo klinikaalii Kansarii Prostate Maryland keessatti

Qorannoo 65 Kansarii Prostate f Maryland keessatti hirmaatuu jiru.

Magaalota Maryland keessatti

Takkalaa qorannoo (Ingiliffa)

IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 120 · Dhiroota · Haaromfame 05-Onk-2026 · NCT07686380

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Walter Reed National Military Medical Center, Bethesda
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06995898

Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Dhiroota · Haaromfame 02-Onk-2026 · NCT01834001

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01441089

Collection of Blood From Patients With Prostate Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Onk-2026 · NCT00923221

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • UM Upper Chesapeake Medical Center, Bel Air
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Onk-2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
  • fi 10 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Johns Hopkins University, Baltimore
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • National Institutes of Health Clinical Center, Bethesda
  • FMH James M Stockman Cancer Institute, Frederick
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

  • Chesapeake Urology Associates, Hanover
  • Chesapeake Urology Associates, Towson
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 40 hanga 75 · Dhiroota · Haaromfame 28-Ful-2026 · NCT07543757

Precision-Based Genomics in Prostate Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Dhiroota · Haaromfame 28-Ful-2026 · NCT04706663

Collection of Blood From Patients With Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT00034216

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

  • University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
  • Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
  • Chesapeake Urology ( Site 0009), Towson
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • University of Maryland Greenebaum Cancer Center, Baltimore
  • Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 22-Ful-2026 · NCT07213674

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dhiroota · Haaromfame 22-Ful-2026 · NCT05588128

Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dhiroota · Haaromfame 22-Ful-2026 · NCT02594202

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Towson
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 18-Ful-2026 · NCT06952803

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 120 · Dhiroota · Haaromfame 17-Ful-2026 · NCT05616650

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 17-Ful-2026 · NCT06925737

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dhiroota · Haaromfame 15-Ful-2026 · NCT04995198

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

  • Chesapeake Urology Research Associates, Towson
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 15-Ful-2026 · NCT07332000

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Anne Arundel Urology, Annapolis
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dhiroota · Haaromfame 14-Ful-2026 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Veterans Administration Medical Center-Baltimore, Baltimore
  • fi 7 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05946213

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dhiroota · Haaromfame 08-Ful-2026 · NCT03354416

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 120 · Dhiroota · Haaromfame 03-Ful-2026 · NCT06096870

Men at High Genetic Risk for Prostate Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 30 hanga 75 · Dhiroota · Haaromfame 03-Ful-2026 · NCT03805919

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06138067

A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 110 · Dhiroota · Haaromfame 03-Ful-2026 · NCT04633252

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dhiroota · Haaromfame 27-Hag-2026 · NCT04692675

Transrectal Ultrasound Robot-Assisted Prostate Biopsy

  • Johns Hopkins Hospital, Baltimore
Namoota walitti qabaa jira
Umuriin 45 hanga 75 · Dhiroota · Haaromfame 26-Hag-2026 · NCT02871726

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • University of Maryland Greenebaum Cancer Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 24-Hag-2026 · NCT07745361

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • Johns Hopkins Hospital, Baltimore
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Dhiroota · Haaromfame 20-Hag-2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • Suburban Hospital, Bethesda
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 19-Hag-2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 100 · Dhiroota · Haaromfame 13-Hag-2026 · NCT05519449

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

  • Johns Hopkins University, Baltimore
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Dhiroota · Haaromfame 12-Hag-2026 · NCT04489719

Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer

  • National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 120 · Dhiroota · Haaromfame 24-Ado-2026 · NCT06161506

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 14-Ado-2026 · NCT05691465

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.